Evaluation of patient adherence with oral anticancer agents

被引:0
|
作者
Kazaz, Seher Nazli [1 ]
Yildirim, Atila [1 ]
机构
[1] Karadeniz Tech Univ, Sch Med, Dept Med Oncol, Trabzon, Turkiye
关键词
Adherence; cancer; modified medication adherence scale-6; modified morisky scale; oral anticancer drugs; MEDICATION ADHERENCE; THERAPY; OUTCOMES; INTERVENTIONS; NONADHERENCE; MANAGEMENT; DURATION; IMATINIB;
D O I
10.4103/jcrt.jcrt_2238_22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The aim of the study was to measure the adherence to oral anticancer treatments in cancer patients using the Modified Morisky Scale (Modified Medication Adherence Scale 6) which has been shown to be valid and reliable in Turkish. Methods:This study was an observational, single-center study involving 300 cancer patients receiving various oral anticancer agents admitted to our outpatient clinic. Motivation and knowledge scores were calculated as per the Modified Medication Adherence Scale 6. Results:The motivation and knowledge levels of the population aged less than 65 years were found to be significantly higher than the geriatric population (>= 65 years old) (P < .003 and P< .001, respectively). It was observed that the patients with higher education levels had significantly higher motivation and knowledge levels (P < .0001 for both). There was no correlation between the motivation and knowledge levels of the patients with gender, marital status, living status, and stage of the disease (P > .05). In addition, the duration of drug use >12 months and the cyclical use of drugs were also found to be significantly associated with increased motivation and knowledge levels. Conclusion:Identifying adherence and related factors, informing patients in detail about the efficacy and toxicity of treatments are the simplest and most basic methods. Particular attention should be paid to patients aged > 65 years, patients with a low level of education, and patients in the earlier stages of their treatments.
引用
收藏
页码:1707 / 1712
页数:6
相关论文
共 50 条
  • [31] Adherence to therapy with oral antineoplastic agents
    Partridge, AH
    Avorn, J
    Wang, PS
    Winer, EP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (09): : 652 - 661
  • [32] SCREENING AND EVALUATION OF ANTICANCER AGENTS
    ZEECHENG, RKY
    CHENG, CC
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1988, 10 (02): : 67 - 101
  • [33] QUALITY IMPROVEMENT MONITORING TO PROMOTE PATIENT SAFETY AND ADHERENCE TO ORAL CHEMOTHERAPEUTIC AGENTS.
    Kim, Heejin
    George, Nancy
    Desjardin, Paula
    Gideon, Jennifer
    Payne, Ann
    Payne, Renee
    ONCOLOGY NURSING FORUM, 2013, 40 (03) : E175 - E175
  • [34] Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population
    Watson, Catherine H.
    Fish, Laura J.
    Falkovic, Margaret
    Monuszko, Karen
    Lorenzo, Amelia
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    Davidson, Brittany A.
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (06): : 1145 - 1153
  • [35] Medication adherence to oral anticancer drugs: systematic review
    Huang, Wen-Chuan
    Chen, Chung-Yu
    Lin, Shun-Jin
    Chang, Chao-Sung
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 423 - 432
  • [36] Factors Influencing Medication Adherence to Oral Anticancer Drugs
    Lee, Yeon Hee
    Jeong, Ihn Sook
    ASIAN ONCOLOGY NURSING, 2013, 13 (04) : 201 - 209
  • [37] Call to Action for Improving Oral Anticancer Agent Adherence
    Levit, Laura A.
    Arora, Shaily
    Kluetz, Paul G.
    Magnuson, Allison
    Rahman, Atiqur
    Harvey, R. Donald
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (10) : 1036 - +
  • [38] Patient Adherence to Biologic Agents in Psoriasis
    Hsu, Der Yi
    Gniadecki, Robert
    DERMATOLOGY, 2016, 232 (03) : 326 - 333
  • [39] Managing adherence, exposure, and toxicity in oral anticancer therapies
    Kazuo Kobayashi
    Journal of Pharmaceutical Health Care and Sciences, 11 (1)
  • [40] Impact of cognitive functions on oral anticancer therapies adherence
    Dos Santos, M.
    Lange, M.
    Clarisse, B.
    Barillet, M.
    Joly, F.
    ANNALS OF ONCOLOGY, 2016, 27